R Ghalie1, C M Richman, J G Bender
1Rush Medical Center, Chicago, IL 60612.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
High-dose therapy with mobilized peripheral blood progenitor cells (PBPC) supports rapid hematologic recovery in solid tumor patients. This approach enables intensified treatment, potentially improving patient outcomes in tandem transplant protocols.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: